Filing Details
- Accession Number:
- 0001127602-10-020455
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-08-03 13:00:00
- Reporting Period:
- 2010-08-02
- Filing Date:
- 2010-08-03
- Accepted Time:
- 2010-08-03 16:03:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875045 | Biogen Idec Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1383731 | F Michael Maclean | Biogen Idec Inc. 133 Boston Post Road Weston MA 02493 | Svp, Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-08-02 | 682 | $56.87 | 20,494 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-08-02 | 917 | $56.85 | 19,577 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-08-02 | 2,201 | $56.84 | 17,376 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-08-02 | 907 | $56.87 | 16,469 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-08-02 | 2,047 | $56.83 | 14,422 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-08-02 | 582 | $56.91 | 13,840 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-08-02 | 2,206 | $56.84 | 11,634 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- Includes 534.5306 shares acquired under the Biogen Idec Inc. employee stock purchase plan on 3/31/2010.
- Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
- This represents the weighted average price for shares sold at a range between $56.46 (low) and $57.17 (high).
- This represents the weighted average price for shares sold at a range between $56.55 (low) and $57.12 (high).
- This represents the weighted average price for shares sold at a range between $56.52 (low) and $57.27 (high).
- This represents the weighted average price for shares sold at a range between $56.54 (low) and $57.27 (high).
- This represents the weighted average price for shares sold at a range between $56.52 (low) and $57.21 (high).
- This represents the weighted average price for shares sold at a range between $56.63 (low) and $57.18 (high).
- This represents the weighted average price for shares sold at a range between $56.45 (low) and $57.19 (high).
Billionaire Hedge Funds
